Assessing the safety of SECURIDRAP® SELFIA® bedding
Official title: Multicenter Clinical Investigation for the Evaluation of Safe Use of SECURIDRAP® SELFIA®
Run by Groupe Mulliez-Flory · NCT05510401 · Data updated 2026-11-12
This study is testing if a new type of bedding is safe for patients with disorientation and behavioral issues over a 15-night period.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 108 (estimated) |
| Sponsor | Groupe Mulliez-Flory Industry-sponsored |
| Locations | 10 sites (Bailleul and 9 other locations) |
| Status | Recruiting |
| Started | May 18, 2022 |
| Main results expected | March 30, 2025 |
| Study ends | July 30, 2025 |
| Registry record updated | November 20, 2024 |
| Trial ID | NCT05510401 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have a medical prescription for SECURIDRAP® SELFIA® and are experiencing disorientation or nocturnal behavioral disorders.
✕Probably not a fit
Patients with severe agitation, those who can easily extract themselves from the bedding, or those without social coverage may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional clinical investigation evaluates the safety of the SECURIDRAP® SELFIA® bedding in patients experiencing disorientation, cognitive impairment, and behavioral disorders. Conducted across nine healthcare facilities in France, the study involves monitoring patients for 15 nights to ensure proper use of the bedding and to record any adverse events. The study is designed to confirm the safety of this second version of the bedding following the withdrawal of its first version from the market. Patients will be included based on specific eligibility criteria, and their experiences will be assessed by an independent evaluator.
Why it matters
Potential benefit: If successful, this study could enhance the safety and comfort of patients with cognitive impairments and behavioral disorders during sleep.
How similar studies have gone: While this study focuses on a specific product, similar approaches in assessing safety and efficacy of medical devices have shown promise in other contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at least 18 years old * Patient having a medical prescription for SÉCURIDRAP® SELFIA® * Patient in phase or state of disorientation * Patient with nocturnal behavior disordre * Patient with major cognitive impairment * Patient at risk of falling into bed * Patient subject to guardianship or curatorship * Patient beneficiary or affiliated to a social security scheme * Patient who has given their participation agreement aand informed consent Exclusion Criteria: * Patient and/or guardianship or curatorship refusing to agree to participate in the clinical investigation * Patient in psychiatry * Patient with severe agitation * Patient who will be agitated once installed in the SÉCURIDRAP® SELFIA® * Patient with intolerance to the medical device * Patient able to extract himself from SÉCURIDRAP® SELFIA® * Patient able to unlock the bed rails by himself * Patient without social coverage or not benefiting from it through a third party * Patient minor, pregnant woman, persons deprived of their liberty * Patient who participating or having participated in another clinical investigation, drug or medical device in the 30 days preceding inclusion
Where it's running
-
CMMF de Bailleul
Bailleul, France Recruiting -
EHPAD l'Aquarelle
Bully-les-Mines, France Recruiting -
Centre Hospitalier d'Hazebrouck
Hazebrouck, France Recruiting -
Centre Hospitalier Le Quesnoy
Le Quesnoy, France Recruiting -
CHU Lille
Lille, France Recruiting -
Ussap- Asm Limoux
Limoux, France Recruiting
Show 4 more locations
-
CHU Lyon
Lyon, France Recruiting -
CHU Rennes
Rennes, France Recruiting -
CHG Roubaix
Roubaix, France Recruiting -
CSSR La Clauze
Saint-Jean-Delnous, France Recruiting
Study contacts
- Principal investigator: François Pr PUISIEUX — CHU Lille
- Study coordinator: Céline BETOUX
- Email: c.betoux@mulliez-flory.fr
- Phone: 0241637810
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
-
Immediate vs progressive standing dual-task training for older adults with mild to moderate cognitive impairment
This study tests whether starting with immediate standing dual-task training is better or worse than progressively increasing the difficulty for older adults with mild to moderate cognitive impairment.
-
Can a phone version of the Mini-Cog identify cognitive impairment before surgery?
This study tests whether a telephone-based Mini-Cog can reliably detect cognitive impairment in adults 65 and older before they have surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.